silybin has been researched along with dinoprostone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Agarwal, R; Kaur, M; Rajamanickam, S; Singh, RP; Velmurugan, B | 1 |
Bannwart, CF; de Medeiros, LT; Golim, MA; Nakaira-Takahagi, E; Peraçoli, MT; Romão, M; Weel, IC | 1 |
Au, AY; Frondoza, CG; Hasenwinkel, JM | 2 |
Chen, CL; Chen, JT; Chen, YH; Liang, CM; Lu, DW; Tai, MC | 1 |
7 other study(ies) available for silybin and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Topics: Adenomatous Polyposis Coli; Animals; Antioxidants; Apoptosis; beta Catenin; Cell Growth Processes; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Intestinal Polyps; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Silybin; Silymarin; Transcriptional Activation | 2010 |
Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Dinoprostone; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interleukin-10; Middle Aged; Monocytes; NF-kappa B; Nitric Oxide; Paracoccidioides; Paracoccidioidomycosis; Signal Transduction; Silybin; Silymarin; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures.
Topics: Animals; Antioxidants; Cells, Cultured; Chemokine CCL2; Dinoprostone; Dogs; Hepatocytes; Interleukin-1beta; Interleukin-8; NF-kappa B; Silybin; Silymarin | 2011 |
Hepatoprotective effects of S-adenosylmethionine and silybin on canine hepatocytes in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cell Survival; Cells, Cultured; Chemokine CCL2; Dinoprostone; Dogs; Gene Expression Regulation; Glutathione; Hepatocytes; Interleukin-1beta; Interleukin-8; Oxidative Stress; S-Adenosylmethionine; Silybin; Silymarin | 2013 |
Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro.
Topics: Animals; Anterior Eye Segment; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aqueous Humor; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; In Vitro Techniques; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Macrophage Activation; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Inbred Lew; RAW 264.7 Cells; Signal Transduction; Silybin; Silymarin; Uveitis | 2017 |